These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37743549)

  • 1. Escherichia coli cytosine deaminase: Structural and biotechnological aspects.
    Vosough P; Vafadar A; Naderi S; Alashti SK; Karimi S; Irajie C; Savardashtaki A; Taghizadeh S
    Biotechnol Appl Biochem; 2024 Feb; 71(1):5-16. PubMed ID: 37743549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alanine-scanning mutagenesis reveals a cytosine deaminase mutant with altered substrate preference.
    Mahan SD; Ireton GC; Stoddard BL; Black ME
    Biochemistry; 2004 Jul; 43(28):8957-64. PubMed ID: 15248753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.
    Stolworthy TS; Korkegian AM; Willmon CL; Ardiani A; Cundiff J; Stoddard BL; Black ME
    J Mol Biol; 2008 Mar; 377(3):854-69. PubMed ID: 18291415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
    Kazlauskas A; Darinskas A; Meškys R; Tamašauskas A; Urbonavičius J
    BMC Cancer; 2019 Mar; 19(1):197. PubMed ID: 30832616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transduction of yeast cytosine deaminase mediated by HIV-1 Tat basic domain into tumor cells induces chemosensitivity to 5-fluorocytosine.
    Lee H; Ryu J; Kim KA; Lee KS; Lee JY; Park JB; Park J; Choi SY
    Exp Mol Med; 2004 Feb; 36(1):43-51. PubMed ID: 15031670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
    Garcia-Sanchez F; Pizzorno G; Fu SQ; Nanakorn T; Krause DS; Liang J; Adams E; Leffert JJ; Yin LH; Cooperberg MR; Hanania E; Wang WL; Won JH; Peng XY; Cote R; Brown R; Burtness B; Giles R; Crystal R; Deisseroth AB
    Blood; 1998 Jul; 92(2):672-82. PubMed ID: 9657770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine.
    Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG
    Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.
    Kievit E; Nyati MK; Ng E; Stegman LD; Parsels J; Ross BD; Rehemtulla A; Lawrence TS
    Cancer Res; 2000 Dec; 60(23):6649-55. PubMed ID: 11118048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
    Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
    Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.
    Pierrefite-Carle V; Baqué P; Gavelli A; Mala M; Chazal M; Gugenheim J; Bourgeon A; Milano G; Staccini P; Rossi B
    J Natl Cancer Inst; 1999 Dec; 91(23):2014-9. PubMed ID: 10580026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase.
    Hamstra DA; Rice DJ; Fahmy S; Ross BD; Rehemtulla A
    Hum Gene Ther; 1999 Aug; 10(12):1993-2003. PubMed ID: 10466633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial cytosine deaminase mutants created by molecular engineering show improved 5-fluorocytosine-mediated cell killing in vitro and in vivo.
    Fuchita M; Ardiani A; Zhao L; Serve K; Stoddard BL; Black ME
    Cancer Res; 2009 Jun; 69(11):4791-9. PubMed ID: 19487291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine.
    Tiraby M; Cazaux C; Baron M; Drocourt D; Reynes JP; Tiraby G
    FEMS Microbiol Lett; 1998 Oct; 167(1):41-9. PubMed ID: 9785450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor therapy mediated by 5-fluorocytosine and a recombinant fusion protein containing TSG-6 hyaluronan binding domain and yeast cytosine deaminase.
    Park JI; Cao L; Platt VM; Huang Z; Stull RA; Dy EE; Sperinde JJ; Yokoyama JS; Szoka FC
    Mol Pharm; 2009; 6(3):801-12. PubMed ID: 19265397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective in vivo radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells transduced with the E. coli cytosine deaminase (CD) gene.
    Gabel M; Kim JH; Kolozsvary A; Khil M; Freytag S
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):883-7. PubMed ID: 9652853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy.
    Mahan SD; Ireton GC; Knoeber C; Stoddard BL; Black ME
    Protein Eng Des Sel; 2004 Aug; 17(8):625-33. PubMed ID: 15381761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photochemical Internalization Enhanced Nonviral Suicide Gene Therapy.
    Sun CH; Berg K; Hirschberg H
    Methods Mol Biol; 2019; 1895():165-176. PubMed ID: 30539537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-viral Suicide Gene Therapy: Cytosine Deaminase Gene Directed by VEGF Promoter and 5-fluorocytosine as a Gene Directed Enzyme/prodrug System in Breast Cancer Model.
    Emamian M; Abbaspour A; Shahani T; Biglari A; Sharafi A
    Drug Res (Stuttg); 2021 Sep; 71(7):395-406. PubMed ID: 34182589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of genetically engineered stem cells expressing cytosine deaminase and interferon-beta or carboxyl esterase on the growth of LNCaP rrostate cancer cells.
    Yi BR; Hwang KA; Kim YB; Kim SU; Choi KC
    Int J Mol Sci; 2012 Sep; 13(10):12519-32. PubMed ID: 23202910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor efficiency of the cytosine deaminase/5-fluorocytosine suicide gene therapy system on malignant gliomas: an in vivo study.
    Lv SQ; Zhang KB; Zhang EE; Gao FY; Yin CL; Huang CJ; He JQ; Yang H
    Med Sci Monit; 2009 Jan; 15(1):BR13-20. PubMed ID: 19114960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.